FLUIDDA nv: Clinical Trials

5 trials sponsored by FLUIDDA nv, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 2 completed. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Terminated 3, Completed 2

Follow FLUIDDA nv: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Effect of Roflumilast in Hyperinflated COPD Patients Using Functional Respiratory Imaging
HRCT scan, Placebo of Roflumilast, Roflumilast - Pulmonary Disease, Chronic Obstructive
Phase 2TerminatedFLUIDDA nv132015-09-012018-03-21
Prospective Study for Transplant Optimization Using Functional Imaging (TROFI)
HRCT scans - Bronchiolitis Obliterans, Lung Transplant Rejection
Phase 2TerminatedFLUIDDA nv102015-07-012018-03-21
Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients
Z7200, Symbicort® Turbohaler® - Asthma, Asthma Chronic
Phase 2CompletedZambon SpA202014-08-012026-09-25
Modelling of the Upper Airway in Children With Controlled Asthma
Cone Beam Computed Tomography - Controlled Asthma
Phase 2CompletedFLUIDDA nv202011-03-012012-10-22
Long-term Effects of Non-invasive Ventilation in Hypercapnic Chronic Obstructive Pulmonary Disease (COPD) Patients
Functional Respiratory Imaging, Lung compliance measurement, Non-invasive ventilation (Respironics) - Chronic Obstructive Pulmonary Disease
Phase 2TerminatedFLUIDDA nv402011-02-012014-01-16

Conditions studied

Asthma (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Bronchiolitis Obliterans (1)  ·  Bronchiolitis Obliterans Syndrome (1)  ·  Hypercapnia (1)

Interventions

Noninvasive Ventilation (1)  ·  Roflumilast (1)

Countries

Belgium (5)  ·  Netherlands (1)

Top investigators

Wilfried De Backer, M.D., M.S. (2)  ·  Wilfried De Backer, MD, PhD (2)  ·  Peter Wijkstra, MD, PhD (1)

NIH funding

2014 (1)